Bill Sponsor
House Bill 124
117th Congress(2021-2022)
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021
Introduced
Introduced
Introduced in House on Jan 4, 2021
Overview
Text
Introduced in House 
Jan 4, 2021
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Jan 4, 2021)
Jan 4, 2021
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 124 (Introduced-in-House)


117th CONGRESS
1st Session
H. R. 124


To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have Sickle Cell Disease.


IN THE HOUSE OF REPRESENTATIVES

January 4, 2021

Mr. Green of Texas introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have Sickle Cell Disease.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Byron Nash Renal Medullary Carcinoma Awareness Act of 2021”.

SEC. 2. Providing incentives for education on risk of renal medullary carcinoma to individuals with Sickle Cell Disease under Medicaid.

(a) In general.—Section 1903(a)(3)(E)(ii) of the Social Security Act (42 U.S.C. 1396b(a)(3)(E)(ii)) is amended by inserting “, renal medullary carcinoma,” after “stroke” each place it appears.

(b) Effective date.—The amendments made by subsection (a) shall apply with respect to items and services furnished on or after the date of the enactment of this Act.